+467.0%
MRNA vs SM
+48.5%
+418.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.2% | +5.6% | +5.4% |
| 7D | -1.1% | +4.6% | -5.6% | -1.4% |
| 30D | +126.1% | +18.2% | +107.9% | +124.4% |
| 3M | +190.0% | +22.5% | +167.5% | +188.1% |
| 6M | +157.2% | +50.6% | +106.7% | +142.8% |
| YTD | +388.2% | +108.1% | +280.1% | +319.4% |
| 1Y | +467.0% | +46.0% | +421.0% | +418.9% |
| All | +467.0% | +48.5% | +418.5% | +418.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SM.
Daily Out/Under-Performance
Portfolio return minus SM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling